Tower Research Capital (TRC)’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $195K | Buy |
21,758
+14,822
| +214% | +$133K | 0.01% | 1799 |
|
|
2025
Q1 | $52K | Sell |
6,936
-16,147
| -70% | -$121K | ﹤0.01% | 2204 |
|
|
2024
Q4 | $174K | Buy |
23,083
+10,583
| +85% | +$79.6K | ﹤0.01% | 1813 |
|
|
2024
Q3 | $95K | Sell |
12,500
-44,054
| -78% | -$335K | ﹤0.01% | 2273 |
|
|
2024
Q2 | $350K | Buy |
56,554
+52,933
| +1,462% | +$327K | 0.01% | 1633 |
|
|
2024
Q1 | $18.4K | Sell |
3,621
-6,799
| -65% | -$34.5K | ﹤0.01% | 3073 |
|
|
2023
Q4 | $62.4K | Buy |
10,420
+5,912
| +131% | +$35.4K | ﹤0.01% | 2982 |
|
|
2023
Q3 | $31.9K | Sell |
4,508
-19,014
| -81% | -$135K | ﹤0.01% | 2971 |
|
|
2023
Q2 | $166K | Buy |
23,522
+11,723
| +99% | +$82.5K | 0.01% | 1681 |
|
|
2023
Q1 | $98K | Sell |
11,799
-4,427
| -27% | -$36.8K | ﹤0.01% | 1887 |
|
|
2022
Q4 | $186K | Sell |
16,226
-30,487
| -65% | -$349K | 0.01% | 1350 |
|
|
2022
Q3 | $589K | Buy |
46,713
+10,852
| +30% | +$137K | 0.01% | 1015 |
|
|
2022
Q2 | $380K | Buy |
35,861
+19,681
| +122% | +$209K | 0.01% | 1305 |
|
|
2022
Q1 | $263K | Sell |
16,180
-8,649
| -35% | -$141K | ﹤0.01% | 1545 |
|
|
2021
Q4 | $344K | Sell |
24,829
-14,056
| -36% | -$195K | 0.01% | 1379 |
|
|
2021
Q3 | $559K | Buy |
38,885
+19,413
| +100% | +$279K | 0.01% | 903 |
|
|
2021
Q2 | $308K | Sell |
19,472
-41,632
| -68% | -$659K | 0.01% | 1585 |
|
|
2021
Q1 | $622K | Sell |
61,104
-2,734
| -4% | -$27.8K | 0.01% | 1060 |
|
|
2020
Q4 | $475K | Sell |
63,838
-379,797
| -86% | -$2.83M | 0.01% | 1026 |
|
|
2020
Q3 | $1.52M | Buy |
443,635
+343,144
| +341% | +$1.18M | 0.02% | 597 |
|
|
2020
Q2 | $479K | Buy |
+100,491
| New | +$479K | 0.02% | 1073 |
|
|
2019
Q2 | – | Sell |
-353
| Closed | -$3K | – | 3666 |
|
|
2019
Q1 | $3K | Buy |
+353
| New | +$3K | ﹤0.01% | 3262 |
|
|
2018
Q1 | – | Sell |
-304
| Closed | -$1K | – | 3256 |
|
|
2017
Q4 | $1K | Sell |
304
-9,135
| -97% | -$30K | ﹤0.01% | 3322 |
|
|
2017
Q3 | $50K | Buy |
9,439
+8,839
| +1,473% | +$46.8K | ﹤0.01% | 1973 |
|
|
2017
Q2 | $3K | Buy |
+600
| New | +$3K | ﹤0.01% | 2179 |
|
|
2017
Q1 | – | Sell |
-7,239
| Closed | -$45K | – | 3059 |
|
|
2016
Q4 | $45K | Buy |
7,239
+6,790
| +1,512% | +$42.2K | ﹤0.01% | 1493 |
|
|
2016
Q3 | $2K | Sell |
449
-1,968
| -81% | -$8.77K | ﹤0.01% | 3029 |
|
|
2016
Q2 | $7K | Buy |
+2,417
| New | +$7K | ﹤0.01% | 3108 |
|
|
2016
Q1 | – | Sell |
-4,237
| Closed | -$44K | – | 4113 |
|
|
2015
Q4 | $44K | Buy |
+4,237
| New | +$44K | 0.01% | 626 |
|
|
2015
Q3 | – | Sell |
-4,673
| Closed | -$70K | – | 3994 |
|
|
2015
Q2 | $70K | Sell |
4,673
-3,129
| -40% | -$46.9K | 0.01% | 1101 |
|
|
2015
Q1 | $71K | Buy |
7,802
+5,221
| +202% | +$47.5K | 0.01% | 1185 |
|
|
2014
Q4 | $31K | Buy |
2,581
+742
| +40% | +$8.91K | ﹤0.01% | 1308 |
|
|
2014
Q3 | $18K | Sell |
1,839
-14,322
| -89% | -$140K | ﹤0.01% | 2372 |
|
|
2014
Q2 | $207K | Buy |
16,161
+14,929
| +1,212% | +$191K | 0.03% | 580 |
|
|
2014
Q1 | $13K | Buy |
1,232
+464
| +60% | +$4.9K | ﹤0.01% | 2326 |
|
|
2013
Q4 | $6K | Sell |
768
-14,860
| -95% | -$116K | ﹤0.01% | 3378 |
|
|
2013
Q3 | $114K | Buy |
15,628
+4,046
| +35% | +$29.5K | 0.01% | 1175 |
|
|
2013
Q2 | $18K | Buy |
+11,582
| New | +$18K | ﹤0.01% | 1802 |
|